Literature DB >> 9158649

Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats.

M Zoli1, R Grimaldi, R Ferrari, I Zini, L F Agnati.   

Abstract

BACKGROUND AND
PURPOSE: The striatum is one of the regions most sensitive to transient forebrain ischemia. After 30-minute ischemia, areas of massive neuronal degeneration are clearly detectable a few hours after the insult and attain their maximal extension 24 hours after the insult. However, for most cellular and neurochemical parameters it is not known whether some recovery occurs at later times. We examined certain cell populations in the caudate putamen at different times after transient ischemia.
METHODS: Adult male Sprague-Dawley rats were subjected to 30-minute forebrain ischemia (four-vessel occlusion model). Six experimental groups were considered: control animals and ischemic animals killed 4 hours, 1 day, 7 days, 40 days, and 8 months after reperfusion. Three striatal cell populations were examined by means of immunocytochemistry coupled to computer-assisted image analysis: vulnerable medium spiny neurons, resistant aspiny neurons, and reactive astrocytes, labeled for their content of dopamine- and cAMP-regulated phosphoprotein mr32 (DARPP-32), somatostatin and neuropeptide Y, and glial fibrillary acidic protein, respectively.
RESULTS: (1) The area containing DARPP-32 immunoreactive neurons was markedly decreased (15% to 20% of control caudate putamen area) at 1 day after reperfusion and partially recovered at the following times (40% to 50% at 7 days and 50% to 60% at 40 days and 8 months after reperfusion). (2) The appearance of reactive astrocytes was precocious (4 hours to 1 day after ischemia) in the medial caudate putamen, the region in which DARPP-32 recovered within 40 days after ischemia, and late (7 to 40 days after ischemia) in the lateral caudate putamen, where no DARPP-32 recovery was detected. (3) Neuropeptide Y/somatostatin-containing neurons resisted the ischemic insult and could be detected in areas devoid of DARPP-32 immunoreactive neurons as long as 8 months after reperfusion.
CONCLUSIONS: The present results show a marked recovery of DARPP-32-positive neurons within 40 days after 30-minute forebrain ischemia in the medial, but not the lateral, caudate putamen. Medial caudate putamen also contains a high density of reactive astrocytes on the first day after ischemia, suggesting that astrocytic support has an important role in the spontaneous recovery of ischemic neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158649     DOI: 10.1161/01.str.28.5.1049

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Molecular mechanisms underlying hypothermia-induced neuroprotection.

Authors:  Yasushi Shintani; Yasuko Terao; Hiroyuki Ohta
Journal:  Stroke Res Treat       Date:  2010-12-01

3.  Mild hypothermia causes differential, time-dependent changes in cytokine expression and gliosis following endothelin-1-induced transient focal cerebral ischemia.

Authors:  An-Gaëlle Ceulemans; Tine Zgavc; Ron Kooijman; Said Hachimi-Idrissi; Sophie Sarre; Yvette Michotte
Journal:  J Neuroinflammation       Date:  2011-05-31       Impact factor: 8.322

4.  The Sphkl/SlP pathway regulates angiogenesis via NOS/NO synthesis following cerebral ischemia-reperfusion.

Authors:  Man-Hua Lv; Shi Li; Yong-Jia Jiang; Wei Zhang
Journal:  CNS Neurosci Ther       Date:  2019-12-08       Impact factor: 5.243

5.  The neuroprotective effect of post ischemic brief mild hypothermic treatment correlates with apoptosis, but not with gliosis in endothelin-1 treated rats.

Authors:  Tine Zgavc; An-Gaëlle Ceulemans; Said Hachimi-Idrissi; Ron Kooijman; Sophie Sarre; Yvette Michotte
Journal:  BMC Neurosci       Date:  2012-08-26       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.